During the past decade, UCSF Nancy Friend Pritzker Psychiatry Building conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCSF Nancy Friend Pritzker Psychiatry Building" are "Depressive Disorder, Treatment-Resistant" (1 trials) and "Obsessive-Compulsive Disorder" (1 trials). Many other conditions were trialed in "UCSF Nancy Friend Pritzker Psychiatry Building" in a lesser frequency.

Most popular intervention types in "UCSF Nancy Friend Pritzker Psychiatry Building" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cortical Stimulation for ACC" (1 trials), "Cortical Stimulation for PFC" (1 trials), "Esketamine 56 mg" (1 trials), "Esketamine 84 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Nancy Friend Pritzker Psychiatry Building" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCSF Nancy Friend Pritzker Psychiatry Building". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UCSF Nancy Friend Pritzker Psychiatry Building, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Nancy Friend Pritzker Psychiatry Building, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".